BRISTOL INVESTMENT FUND, LTD.

Company

IOVANCE BIOTHERAPEUTICS, INC.

Filed

November 5, 2010

Accession Number

0001019687-10-003936

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →